Jardiance 10 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DR26F9CJ3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,907
Award facts
- Contract value 100% obligated
- $10,906.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $10,906.86. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The contract is expected to be completed by November 21, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime contract vehicle running through December 2026 that enables the company to supply pharmaceuticals and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company maintains an extensive portfolio of federal medical procurement contracts with the Defense Logistics Agency, supplying a comprehensive range of pharmaceuticals including diabetes medications, neurological treatments, pain management drugs, antibiotics, vaccines, and specialized medical supplies. The contract award reflects AmerisourceBergen's established capability to compete successfully in federal pharmaceutical procurement and fulfill the Defense Health Agency's medical supply requirements through the DLA Medical Supply Chain.
Quick answers
Who was awarded contract SPE2DR26F9CJ3?
SPE2DR26F9CJ3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F9CJ3 worth?
The government has obligated $10,907 on SPE2DR26F9CJ3.
Is contract SPE2DR26F9CJ3 an order under another contract?
Yes. SPE2DR26F9CJ3 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9CJ3 competed?
The extent of competition for SPE2DR26F9CJ3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award